Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Metastatic Prostate Adenocarcinoma

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Rouen University Hospital

Rouen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient monitored for castration-resistant metastatic prostate
Patients starting a first or second line treatment as part of castration resistance
Patient not objecting to the study after reading the information letter
Patient aged over 18 years

Exclusion criteria

Patient monitored for non-metastatic prostate cancer
Patient monitored for castration-nonresistant prostate cancer
Patient not able to understand the information letter

Treatment and study plan

Local chemotherapy

Drug

Local chemotherapy will be administrated according to local recommendation

Primary outcomes

Number of alive patient

Time frame: 3 years

Secondary outcomes

Number of alive patient disease free

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: OPALE

Important dates

Study start: 2018
Primary completion: 2026
Study completion: 2026
First posted: Aug 2, 2018
Registry last updated: Mar 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting